                               NIH Public Access
                               Author Manuscript
                               Cell. Author manuscript; available PMC 2013 October 25.
                           Published final edited form 
NIH-PA Author Manuscript




                            Cell. 2013 April 25; 153(3): 614â€“627. doi:10.1016/j.cell.2013.03.040.



                           Proteasome regulation ADP-ribosylation
                           Park F. Cho-Park Hermann Steller*
                           Strang Laboratory Apoptosis Cancer Biology, Howard Hughes Medical Institute,                            Rockefeller University, 1230 York Avenue, New York, NY 10021, USA

                           Summary
                                 Protein degradation ubiquitin-proteasome central cell homeostasis survival.
                                 Defects process associated diseases cancer neurodegenerative
                                 disorders. 26S proteasome large protease complex degrades ubiquitinated proteins.
                                 ADP-ribosylation promotes 26S proteasome activity Drosophila                                  human cells. identify ADP-ribosyl transferase Tankyrase (TNKS) 19S assembly
                                 chaperones dp27 dS5b direct binding partners proteasome regulator PI31. TNKS-
                                 mediated ADP-ribosylation PI31 drastically reduces affinity 20S proteasome Î±-subunits
NIH-PA Author Manuscript




                                 relieve 20S repression PI31. Additionally, PI31 modification increases binding                                  sequestration dp27 dS5b 19S regulatory particles, promoting 26S assembly. Inhibition
                                 TNKS RNAi small-molecule inhibitor, XAV939, blocks process reduce
                                 26S assembly. results unravel mechanism proteasome regulation targeted
                                 existing small-molecule inhibitors.


                           Introduction
                                             Selective protein degradation plays central role removal misfolded, potentially
                                             toxic proteins, control cell cycle progression, regulation gene expression,                                              changes cell size morphology (Baumeister et al., 1998; Demartino Gillette, 2007;
                                             Finley, 2009; Glickman Ciechanover, 2002; Hershko, 2005; Hershko Ciechanover,
                                             1998; Murata et al., 2009; Tanaka et al., 2012).  abnormal protein degradation                                              associated wide range human diseases, cancer, muscle wasting diseases
                                             neurodegenerative disorders (Glickman Ciechanover, 2002; Goldberg, 2007;
                                             Hershko Ciechanover, 1998). selective degradation intracellular proteins                                              carried ubiquitin-proteasome (UPS) (Finley, 2009; Glickman NIH-PA Author Manuscript




                                             Ciechanover, 2002; Hershko Ciechanover, 1998; Varshavsky, 2012). Proteins tagged
                                             poly-ubiquitin chains hydrolyzed small peptides 26S proteasome                                              energy-dependent manner (Baumeister et al., 1998; Besche et al., 2009b; Demartino                                              Gillette, 2007; Finley, 2009; Tanaka et al., 2012; Tomko Hochstrasser, 2011).

                                             26S proteasome large protease complex composed catalytic 20S subunit                                               known 20S core particle) 19S regulatory particle caps ends                                              20S proteasome (Baumeister et al., 1998; Besche et al., 2009b; Demartino Gillette,
                                             2007; Finley, 2009; Lander et al., 2012; Lasker et al., 2012; Murata et al., 2009; Tanaka et
                                             al., 2012; Tomko Hochstrasser, 2011). assembly activity 26S proteasome


                           Â© 2013 Elsevier  rights reserved
                           *
                            Corresponding: author: steller@rockefeller.edu.
                           Publisher's Disclaimer: PDF file unedited manuscript accepted publication. service                            customers providing early version manuscript. manuscript undergo copyediting, typesetting, review                            resulting proof published final citable form. note production process errors                            discovered affect content, legal disclaimers apply journal pertain.
                            Cho-Park Steller                                                                                           Page 2


                                                  tightly regulated large number loosely associated proteins function                                                   regulators cofactors (Besche et al., 2009b; Finley, 2009; Tanaka et al., 2012; Tomko                                                   Hochstrasser, 2011). factor PI31, evolutionarily conserved regulator NIH-PA Author Manuscript




                                                  proteasome activity (Bader et al., 2011; Chu-Ping et al., 1992; McCutchen-Maloney et al.,
                                                  2000; Zaiss et al., 1999). PI31 initially identified based ability inhibit 20S
                                                  proteasome activity vitro (Chu-Ping et al., 1992; McCutchen-Maloney et al., 2000; Zaiss
                                                  et al., 1999).  PI31 activate 26S proteasome vitro, mutational
                                                  inactivation corresponding gene Drosophila causes lethality, reduced proteasome
                                                  activity defects protein degradation vivo (Bader et al., 2011).  PI31
                                                  serves crucial physiological function activator 26S proteasome activity. C-
                                                  terminus PI31 contains functionally important HbYX (Hydrophobic residue-Tyrosine-
                                                  amino acid) motif, commonly modulators proteasome activity,                                                   Rpt base subunits 19S regulatory particle (Gillette et al., 2008; Rabl et al., 2008;
                                                  Smith et al., 2007). suggests PI31 bind 20S particle HbYX-motif,
                                                  cause inhibition hindering substrate access enzymatic core (Bader et
                                                  al., 2011; McCutchen-Maloney et al., 2000).  precise molecular mechanism                                                   PI31 modulates proteasome activity remains unknown. Previous work indicated
                                                  PI31 function regulated vivo increase 26S proteasome activity conditions
                                                  maximal proteolytic activity required, example removal cellular
                                                  proteins terminal differentiation sperm (Bader et al., 2011). gain                                                   insight regulation PI31 activity looked novel binding partners NIH-PA Author Manuscript




                                                  protein identified ADP-ribosyl transferase tankyrase (TNKS) direct interactor
                                                  modulates PI31 activity. TNKS-mediated ADP-ribosylation PI31 necessary                                                   ability protein stimulate 26S proteasome function, inhibition TNKS reduces
                                                  26S proteasome activity Drosophila mammalian cells. TNKS-mediated ADP-
                                                  ribosylation PI31 drastically reduces affinity protein binding 20S
                                                  proteasome Î±-subunits relieves 20S repression PI31. identified                                                   19S assembly chaperones dp27 dS5b binding partners PI31. case, ADP-
                                                  ribosylation PI31 causes increased binding dp27 dS5b, sequestration                                                   assembly chaperones 19S regulatory particles, promotes 26S assembly.                                                   results reveal novel mechanism proteasome regulation define TNKS-inhibitors                                                   new class proteasome modulators utility clinic.

                              Results
                              dTNKS interacts DmPI31
                                                  gain insight mechanism PI31-mediated proteasome regulation, looked                                                   binding partners protein. purpose, screened Drosophila embryo cDNA
                                                  library Far-Western analysis using P32-labeled HMK-tagged Drosophila PI31 (DmPI31)
NIH-PA Author Manuscript




                                                  probe. led identification Drosophila tankyrase (dTNKS, CG4719)                                                   potential interacting protein (data shown). dTNKS protein 44  homologous human
                                                  tankyrase 1 2 (hTNKS1/2; Figure S1A).  used IP experiments investigate
                                                  endogenous interactions DmPI31 dTNKS (Figure 1B). Extracts wild-type
                                                  (WT) embryos immunoprecipitated anti-DmPI31 blots probed                                                   antibody raised dTNKS (Figures 1A S1B). experiments dTNKS
                                                  DmPI31 form complex vivo (Figure 1B). expressed FLAG-tagged
                                                  dTNKS HA-tagged DmPI31 human 293 cells establish cell culture                                                   subsequent interaction studies (Figure 1C).  IP experiments extracts                                                   cells showed presence DmPI31:dTNKS complex (Figure 1C).

                                                  TNKS belongs poly(ADP-ribose) polymerase (PARP) super-family (Dâ€™Amours et al.,
                                                  1999; Hsiao Smith, 2008; Smith et al., 1998). TNKSs play diverse roles telomere
                                                  maintenance, centrosome maturation, Wnt signaling, embryonic development 
                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                           Page 3


                                                  pathogenesis Cherubism (Guettler et al., 2011; Hsiao Smith, 2008; Huang et al.,
                                                  2009; Levaot et al., 2011). TNKSs recruit modify target proteins ADP-ribosylation
                                                  using Ankyrin (ANK) PARP domains (Figure S1A) (Guettler et al., 2011; Hsiao
NIH-PA Author Manuscript




                                                  Smith, 2008; Huang et al., 2009; Levaot et al., 2011; Morrone et al., 2012; Smith et al.,
                                                  1998). Unlike mammals, isoforms TNKS partially redundant function
                                                  present, Drosophila genome contains TNKS (Chiang et al., 2008; Chiang et
                                                  al., 2006; Hsiao et al., 2006; Hsiao Smith, 2008; Yeh et al., 2009). order identify
                                                  region dTNKS responsible interaction DmPI31, generated
                                                  truncations dTNKS lack ANK SAM-PARP domains tested                                                   binding DmPI31 (Figures 1D 1E). SAM-PARP domains                                                   dispensable DmPI31-binding, deletion ANK domain dTNKS Î”ANK mutant
                                                  prevented formation DmPI31:dTNKS complex (Figure 1E). suggests                                                   dTNKS binds DmPI31 ANK-domain.

                                                  hallmark TNKS-binding partners presence canonical TNKS-binding motif
                                                  (RxxGxGxE/D) (Guettler et al., 2011; Hsiao Smith, 2008; Levaot et al., 2011). DmPI31
                                                  contains good fit consensus motif N-terminus (Figure 1F). investigate                                                   functional importance motif, mutated sequence altering amino acids
                                                  (RG49/54AA) tested binding dTNKS. mutant protein longer able form
                                                  complex dTNKS, indicating motif required interaction dTNKS
                                                  (Figure 1G, lane 2). characterize DmPI31-dTNKS interaction, generated
NIH-PA Author Manuscript




                                                  DmPI31 mutants C-terminal residues, including HbYX motif,                                                   mutated deleted (L210A, D211K, F241A P243A Î”HbYX - Figure 1G; lanes 3â€“
                                                  7). DmPI31D211K DmPI31P243A mutants retained ability bind dTNKS,
                                                  DmPI31L210A DmPI31F241A unable form complex dTNKS (Figure 1G).
                                                  Furthermore, deletion HbYX motif DmPI31 abrogated interaction                                                   DmPI31 dTNKS (Figure 1G, lane 7). suggests dTNKS uses ANK-domain
                                                  bind DmPI31, N-terminal TNKS-binding motif C-terminal
                                                  HbYX domain DmPI31 required interaction dTNKS.

                              dTNKS ADP-ribosylates DmPI31
                                                  TNKSs modulate activity target proteins ADP-ribosylation (Hsiao Smith,
                                                  2008; Huang et al., 2009; Smith et al., 1998).  investigated DmPI31                                                   substrate dTNKS-mediated ADP-ribosylation.  used Western blot analysis
                                                  monoclonal antibody recognizing poly ADP-ribosylation (PAR)                                                   DmPI31 ADP-ribosylated vivo (Figure 2A, lane 3).  performed vitro
                                                  ADP-ribosylation assay incubating Biotin-labeled NAD+ DmPI31                                                   FLAG-dTNKSWT dTNKS Î”PARP recombinant proteins (Figure 2B).                                                   experiments demonstrated dTNKS directly ADP-ribosylate DmPI31 vitro, NIH-PA Author Manuscript




                                                  activity requires PARP domain.

                                                  investigated significance TNKS-mediated ADP-ribosylation PI31 function                                                   proteasome regulation, Drosophila subsequently mammalian cells.                                                   purpose, took advantage small molecule inhibitor hTNKS1/2, XAV939 (Huang et
                                                  al., 2009). XAV939 discovered screen small molecules affecting Wnt/Î²-
                                                  catenin signaling pathway (Huang et al., 2009). XAV939 highly specific inhibitor                                                   hTNKS1/2 (Kd = 0.09 Î¼M) anti-cancer effects APC-deficient colorectal
                                                  cancer cells (Huang et al., 2009). tested ability XAV939 inhibit dTNKS                                                   able inhibit auto-ADP-ribosylation activity dTNKS, PARP
                                                  (Figures 2C S2A) (Gibson Kraus, 2012; Smith et al., 1998).  XAV939                                                   effective specific TNKS-inhibitor Drosophila.




                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                            Page 4


                              TNKS regulates proteasome activity ADP-ribosylation
                                                  DmPI31 required optimal proteasome activity vivo, dTNKS
                                                  post-translationally modulate DmPI31, explored possibility inhibition NIH-PA Author Manuscript




                                                  TNKS affects proteasome function.  examined effect TNKS-inhibitor
                                                  XAV939 26S proteasome activity Drosophila. Extracts 0â€“2h WT embryo                                                   treated different compounds assayed changes proteasome activity (Figure
                                                  2E). Treatment XAV939 significantly reduced 26S proteasome activity (Figure 2E).
                                                  treatment XAV939 did cause complete inhibition proteasome activity
                                                  observed MG312, effect similar inactivation DmPI31 (Bader et al.,
                                                  2011). results consistent requirement dTNKS DmPI31-mediated
                                                  proteasome activation. asked XAV939 inhibit proteasome
                                                  activity mammalian cells. purpose, treated 293 cell extracts XAV939                                                   measured 26S proteasome activity (Figure 2F).  exposure                                                   compound decreased proteasome activity. Similar results obtained IWR-1,
                                                  TNKS inhibitor structurally unrelated XAV939 (Figure S2B) (Chen et al.,
                                                  2009; Narwal et al., 2012). supports conclusion observed decrease                                                   proteasome activity caused TNKS inhibition, unrelated target effect                                                   XAV939. corroborate idea, used RNAi target TNKS                                                   Drosophila mammalian cells.  expressed RNAi dTNKS                                                   Drosophila retina background compromised proteasome activity (Figure 3).
                                                  Specifically, expression temperature sensitive dominant negative mutant 20S
NIH-PA Author Manuscript




                                                  proteasome Î²2 Î²6 subunits causes rough, reduced eye (Belote Fortier, 2002).
                                                  Expression RNAi dTNKS enhanced phenotype, similarly                                                   previously observed reduction DmPI31 function (Figures 3Câ€“E) (Bader et al., 2011).
                                                   regulation dTNKS reduces proteasome activity vivo. Finally, used
                                                  siRNA knock hTNKS1 hTNKS2 human 293 cells (Figure 2D).                                                    significant reduction 26S proteasome activities observed (Figure 2G). Taken
                                                   results TNKS stimulates proteasome activity ADP-ribosylation
                                                  PI31.

                              ADP-ribosylation blocks DmPI31 inhibition 20S proteasomes
                                                  Best known role DNA damage, ADP-ribosylation transient post-translational
                                                  modification drastically alter physical properties target proteins (Chambers et
                                                  al., 2012; Gagne et al., 2006; Gibson Kraus, 2012; Wang et al., 2009). order                                                   understand biochemical consequences TNKS-mediated ADP-ribosylation PI31,                                                   investigated modification affects binding properties protein.                                                   mammalian cells, PI31 bind 20S proteasomes (McCutchen-Maloney et al., 2000;
                                                  Zaiss et al., 1999). Likewise, DmPI31 bind 20S proteasomes NIH-PA Author Manuscript




                                                  Drosophila (Figure 4A). particular, DmPI31 bound selectively Î±-subunits: Î±1,
                                                  Î±3, Î±4 Î±6, Î±2 Î±5 (Figure 4A).  used immunoprecipitation
                                                  experiments evaluate role ADP-ribosylation DmPI31: Î± 4-complex.
                                                  unmodified PI31 strongly interacted Î±4, binding ADP-ribosylated
                                                  version significantly diminished (Figure 4B). Consistent observed change                                                   DmPI31 affinity Î±-subunits, ADP-ribosylation interfered ability
                                                  PI31 inhibit 20S proteasome particles (Figure 4C). results demonstrate                                                   ADP-ribosylation blocks binding DmPI31 20S subunits relieves repression                                                   proteolytic activity protein.

                              dTNKS DmPI31 actively participates proteasome assembly
                                                  TNKS-mediated ADP-ribosylation PI31 affects 20S 26S proteasome
                                                  activities, investigated possible role TNKS PI31 26S proteasome assembly.
                                                   performed Superose 6 gel filtration (FPLC) assays native gel analyses 
                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                             Page 5


                                                  study effect TNKS-inhibitor XAV939 proteasome assembly. Drosophila embryos
                                                  ideal study effects 26S assembly ~65  proteasomes exist                                                   20S particles (Nickell et al., 2007). XAV939 treatment Drosophila embryo extracts led NIH-PA Author Manuscript




                                                  significant shift Rpt bands lighter fractions compared controls,                                                   prevented formation 26S proteasomes analyzed native gels (Figures 5A, 5B,
                                                  S3A S3B). indicates TNKS activity promotes 26S proteasome assembly.

                                                  examined effect PI31 26S proteasome assembly.  used gel
                                                  filtration assays analyze embryo extracts supplemented high concentrations 
                                                  DmPI31 recombinant protein (Figure 5C).  addition DmPI31 caused                                                   significant change proteasome architectural landscape redistributing Rpt3 bands
                                                  (Figure 5C). observed increase Rpt3 monomers (Figure 5C; panel -
                                                  fractions 20â€“23). effects seen WT DmPI31, mutant lacking                                                   HbYX motif (Figure 5C). increase Rpt3 monomers explained ability                                                   PI31 bind 19S assembly chaperones   known stabilize assembly
                                                  19S regulatory particle 26S proteasome (Funakoshi et al., 2009; Kaneko et al.,
                                                  2009; Le Tallec et al., 2009; Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009).
                                                  Collectively, results TNKS activity PI31 modulate 26S
                                                  proteasome assembly, suggest role PI31 promoting 19S stability.

                              19S assembly chaperones interact DmPI31
NIH-PA Author Manuscript




                                                  better understand role DmPI31 proteasome assembly, looked additional
                                                  DmPI31 binding partners. screen revealed dTNKS DmPI31 interactor,
                                                  discovered proteasome-associated proteins, Drosophila p27 (dp27; CG9588)
                                                  Drosophila S5b (dS5b; CG12096). p27 S5b play known role 19S assembly
                                                  chaperones  Rpn14 Nas6, bind 19S Rpt subunits foster orderly
                                                  proteasome assembly (Funakoshi et al., 2009; Kaneko et al., 2009; Le Tallec et al., 2009;
                                                  Park et al., 2009; Roelofs et al., 2009; Saeki et al., 2009). yeast human,                                                   Drosophila homologs 19S assembly chaperones (dp27: 41  dS5b: 23.3 
                                                  homologous; Figures 6B S5A) essential genes required organismal viability
                                                  (Figures 3Fâ€“L, S4A S4B). IP experiments anti-DmPI31 using Drosophila embryo
                                                  extracts followed Western analysis using anti-dp27 reveal DmPI31 binds dp27                                                   vivo (Figures 6A S4C). identify DmPI31 residues involved dp27 dS5b
                                                  binding, used point mutants previously employed map DmPI31:dTNKS
                                                  interaction (Figure 1G). mutants defective TNKS-binding (RG49/54AA) failed                                                   destabilize DmPI31:assembly chaperone complex, mutating conserved C-terminus                                                   DmPI31 (L210, F241 HbYX motif) disrupted interactions (Figures 6C S5B).
                                                  results C-terminal HbYX motif required formation                                                   complex DmPI31 assembly chaperones dp27 dS5b.
NIH-PA Author Manuscript




                                                  Despite structural differences, 19S assembly chaperones use common mechanism                                                   bind 19S Rpt subunits (Barrault et al., 2012; Funakoshi et al., 2009; Lee et al., 2011; Park
                                                  et al., 2009; Roelofs et al., 2009; Saeki et al., 2009; Takagi et al., 2012). dp27                                                   dS5b interact DmPI31 C-terminus, performed protein sequence alignments
                                                  dp27, dS5b dRpn14. identified putative DmPI31-binding motifs  III;
                                                  Figure 6D). order test functional relevance motifs, mutated sites
                                                  examined consequences DmPI31 interaction (Figures 6E S5C). Point
                                                  mutations replaced key residues motifs III dp27 dS5b (dp27: E9A                                                   R187A; dS5b: E44A R263A) failed recruit DmPI31, indicating requirement                                                   motifs interaction DmPI31 (Figures 6E S5C). results suggest                                                   dp27 dS5b novel interacting partners DmPI31.




                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                               Page 6


                              ADP-ribosylation promotes 26S proteasome assembly increasing affinity DmPI31
                              assembly chaperones
                                                  ADP-ribosylation PI31 modulates 20S proteasome activity altering affinity NIH-PA Author Manuscript




                                                  Î±-subunits (Figure 4), wondered post-translational modification affect
                                                  interaction 19S assembly chaperones p27 S5b. examine possibility,                                                   performed anti-FLAG IP experiment using 293 cell extracts standardized FLAG-
                                                  dp27 HA-dRpt5 expression, followed rigorous washing addition                                                   incremental amounts vitro modified DmPI31. effects ADP-ribosylated DmPI31
                                                  stability dp27:dRpt5 dS5b:dRpt2 complexes visualized Western blot
                                                  (Figures 7A S6A). Countering effect Î±4 subunit, compared                                                   unmodified version, ADP-ribosylation considerably increased ability DmPI31                                                   recruit assembly chaperones, sequestering away Rpt base subunits                                                   dose-dependent manner (compare Figures 7A S6A Figures 7B S6B,
                                                  respectively). results, presented earlier indicate ADP-
                                                  ribosylation directly modifies DmPI31 affinity proteasome-associated proteins.

                                                  Evidence role PI31 activator 26S proteasome previously based                                                   requirement protein normal proteasome activity vivo, ability                                                   protein stimulate 26S proteasome activity vitro (Bader et al., 2011). modification
                                                  ADP-ribosylation differentially affects interaction DmPI31 different proteasome
                                                  proteins, investigated consequences PI31-modification 26S proteasome activity
NIH-PA Author Manuscript




                                                  vitro. ADP-ribosylated DmPI31 significantly potent stimulating                                                   chymotrypsin-like activity purified 26S proteasomes vitro (Figure 7C). Furthermore,
                                                  modified DmPI31 incubated purified 20S 19S particles analyzed                                                   native gels, saw ADP-ribosylation increased ability DmPI31 promote                                                   novo 26S assembly vitro (Figure 7D). Finally, addition ADP-ribosylated DmPI31
                                                  extracts pre-treated XAV939 reversed inhibitory effect compound 26S
                                                  proteasome assembly able increase 26S proteasome assembly
                                                  (Figure 7E). surplus PI31 overcome effects XAV939, albeit
                                                  efficiently modified counterpart. consistent observation                                                   unmodified PI31 bind sequester 19S assembly chaperones (Figure S6B). Taken
                                                   data dTNKS-dependent ADP-ribosylation DmPI31 stimulates 26S
                                                  proteasome activity promoting 26S assembly.

                              Discussion
                                                  increasingly clear proteasome, thought constitutively
                                                  active protease complex, dynamically regulated meet changing proteolytic needs                                                   cell (Demartino Gillette, 2007; Glickman Ciechanover, 2002; Hershko NIH-PA Author Manuscript




                                                  Ciechanover, 1998). poly-ubiquitination substrates central select specific
                                                  proteins degradation, additional mechanisms exist account plasticity                                                   proteasome activity (Crosas et al., 2006; Demartino Gillette, 2007; Hanna et al., 2007;
                                                  Kurucz et al., 2002; Murata et al., 2009; Peth et al., 2009; Peth et al., 2013; Peth et al., 2010;
                                                  Princiotta et al., 2001).  identified TNKS novel regulator proteasome
                                                  activity Drosophila mammalian cells. Specifically, TNKS-
                                                  mediated ADP-ribosylation PI31 alters affinity protein 20S proteasome Î±-
                                                  subunits 19S assembly chaperones stimulates 26S proteasome assembly.
                                                  results support model TNKS activates evolutionarily conserved
                                                  proteasome regulatory protein, PI31, ADP-ribosylation (Figure 7F). PI31                                                   physiologically required optimal 26S proteasome activity vivo, inactivation                                                   corresponding gene Drosophila causes reduced protein breakdown organismal
                                                  lethality (Bader et al., 2011). Inhibition TNKS RNAi specific small-
                                                  molecule inhibitor, XAV939, blocked ADP-ribosylation PI31 impaired 26S

                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                              Page 7


                                                  proteasome activity similar inactivation PI31. suggested PI31 act                                                   modulator proteasome assembly reversibly associating 20S proteasome (Besche
                                                  et al., 2009a; McCutchen-Maloney et al., 2000; Tai et al., 2010; Tanahashi et al., 1999; Zaiss
NIH-PA Author Manuscript




                                                  et al., 1999; Zaiss et al., 2002). support idea, PI31 modification                                                   TNKS facilitates assembly 26S proteasome acting crucial stages (Figure
                                                  7F).  TNKS-mediated ADP-ribosylation decreases affinity PI31 Î±4 subunits
                                                  20S particle. dislodges PI31 20S proteasomes prevents PI31                                                   inhibiting 20S activity. free, modified PI31 competes Rpt subunits sequester
                                                  assembly chaperones p27 S5b away 19S regulatory particles,                                                   promoting capping 20S 19S particles. consistent previous
                                                  observations overexpression p27, S5b Rpn14/PAAF1 proteins negatively
                                                  affected proteasome assembly (Kaneko et al., 2009; Lassot et al., 2007; Park et al., 2005;
                                                  Shim et al., 2012). acting 20S particles assembly chaperones, PI31 appears
                                                  function central regulator 26S proteasome assembly (Figure 7F). Significantly,                                                   process disrupted existing small-molecule compounds: TNKS-inhibitors
                                                  represent novel class compounds inhibit 26S activity interfering                                                   proteasome assembly.

                                                  PI31 required normal proteasome activity vivo, stimulate activity
                                                  purified 26S proteasome vitro (Bader et al., 2011). order explain finding,
                                                  invoke possibility purified 26S proteasomes used experiments contain
NIH-PA Author Manuscript




                                                  associated proteins, including 19S assembly chaperones. consistent observations
                                                  showing p27 S5b association purified 26S proteasome (Besche et al., 2009a;
                                                  Deveraux et al., 1995; Gomes et al., 2006; Tai et al., 2010; Watanabe et al., 1998).
                                                  Furthermore, unmodified PI31 bind assembly chaperones, albeit lower
                                                  efficiency (Figure S6B). Taken  results suggest PI31 stimulates
                                                  proteasome activity vitro increasing 26S particles.

                                                  rate intracellular protein degradation dramatically affected various signals,
                                                  including metabolic state cell (Glickman Ciechanover, 2002). example,
                                                  caloric restriction cause severe reduction skeletal muscles, humans loose large
                                                  fraction muscle mass aging. appears evolved                                                   protective mechanism cope food shortage, muscle atrophy highly
                                                  debilitating process occurs various diseases, cancer cachexia, AIDS,
                                                  renal failure, neuro-degenerative diseases. cases, proteasome activity                                                   responsible protein breakdown cellular atrophy, direct connection                                                   metabolism proteasome activity established. NAD+ source
                                                  ADP-ribose group, proteasome regulation TNKS provides potential new link
                                                  cell metabolism regulation protein degradation (Gibson Kraus,
NIH-PA Author Manuscript




                                                  2012). ADP-ribosylation short half-life (1â€“2 min), ideally suited                                                   rapidly signal transient changes cell physiology (Chambers et al., 2012; Gibson                                                   Kraus, 2012; Lindahl et al., 1995; Wang et al., 2009). speculate TNKS-mediated
                                                  activation PI31 serve stimulate proteasome activity cells need                                                   dynamically boost proteolytic capacity meet changing demands,                                                   cellular remodeling, stress caloric restriction. possible                                                   activation PI31 occurs specific subcellular compartments, example                                                   nucleus, specific neuronal processes undergoing pruning, synapses                                                   remodeling. way, possible locally fine-tune assembly activity                                                   26S proteasomes meet cellâ€™s changing needs controlled proteolysis.

                                                  proteasome validated drug target cancer therapy bortezomib (â€œVelcadeâ€?),
                                                  inhibits chymotrypsin-like activity proteasome, approved                                                   treatment multiple myeloma mantle cell lymphoma (Goldberg, 2012; Kisselev et


                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                          Page 8


                                                  al., 2012; Raab et al., 2009). Problems associated bortezomib include notable                                                   effects, peripheral neuropathy drug resistance (Goldberg, 2012; Kisselev et al.,
                                                  2012; Raab et al., 2009).  drugs inhibit proteasome activity separate
NIH-PA Author Manuscript




                                                  mechanism considerable clinical value. findings suggest TNKS-
                                                  inhibitors, XAV939 IWR-1, useful treatment multiple
                                                  myeloma, mantle cell lymphoma cancers sensitive proteasome inhibition.
                                                  Consistent idea, preliminary evidence XAV939 block growth
                                                  multiple myeloma cells (Figure S6C). inhibiting proteasome activity                                                   entirely distinct mechanism, TNKS-inhibitors expected block maximal activation
                                                  26S function, basal activity proteasome fewer                                                   effects (Figure 7F). Interestingly, XAV939 shown effective                                                   colorectal cancer cells thought antagonize Wnt-signaling preventing                                                   degradation axin (Huang et al., 2009).  contribution proteasome inhibition
                                                  paradigm determined. Proteasome regulation tankyrase-mediated
                                                  ADP-ribosylation provides unexpected new mechanism regulate protein degradation
                                                  targeted small-molecule inhibitors.

                              Experimental Procedures
                              Recombinant Protein Purification Far-Western screening cDNA library
                                                  purification DmPI31, DmPI31Î”HbYX, HMK-DmPI31 
NIH-PA Author Manuscript




                                                  dTNKSÎ”PARP fusion proteins, E.coli BL21 (Invitrogen) transformed pET28-
                                                  DmPI31, pET28 DmPI31Î”HbYX, pET101 HMK-DmPI31 pET101 
                                                  dTNKSÎ”PARP constructs. Following 2h induction 37Â°C 0.1 mM IPTG, fusion
                                                  proteins purified TALONâ„¢ Metal Affinity resin (BD Bioscience) according                                                   manufacturerâ€™s instructions. purification FLAG-dTNKS FLAG-dPARP,
                                                  HEK293 cell extracts expressing pcDNA3.2-FLAG-dTNKS pcDNA3.2-FLAG-
                                                  dPARP constructs incubated anti- FLAGÂ®M2-Affinity Gel (Sigma) 3h                                                   purified using FLAGÂ® peptide (Sigma) according manufacturerâ€™s instructions. Far-
                                                  Western screening cDNA library performed previous described (Pause et al.,
                                                  1994) using Drosophila Î» cDNA library (Stratagene).

                              Cell Culture/Growth assay
                                                  Cationic lipid reagent (20 Î¼l Lipofectamine 2000; Invitrogen) diluted serum free
                                                  media (Opti-MEM; Invitrogen) transfection Human Embryonic Kidney 293 cells
                                                  (100mm dish). Following 5h incubation, medium replaced Dulbeccoâ€™s
                                                  Modified Eagle Medium(DMEM; Invitrogen) supplemented 10  Fetal Bovine Serum
                                                  (FBS). Transfected cells harvested PBS 48h following addition serum
NIH-PA Author Manuscript




                                                  containing media. cells lysed repeated freeze/thaw cycles 600 Î¼l                                                   lysis buffer (20mM Hepes-KOH, pH 7.6, 200mM KCl, 0.5mM EDTA, 10  glycerol, 1 
                                                  Triton X-100 Protease Inhibitor Cocktail (Completeâ„¢; Roche)) contains RNAse                                                   (50 Î¼g/ml; Sigma). Cell debris pelleted centrifugation, protein concentration
                                                  supernatant determined using Bio-Rad assay. siRNAs purchased                                                   Invitrogen (sequences shown Table S1) transfected 293 cells final
                                                  concentration 50nM/100mm dishes using Lipofectamine 2000. Effects drug treatment
                                                  U266 multiple myeloma cell growth performed using 0.1 Î¼M bortezomib 5
                                                  Î¼M XAV939 low FBS (0.5 ) RPMI media, 96 plates seeded ~8000
                                                  cells  Samples assayed growth/viability using PrestoBlueÂ® Cell Viability
                                                  Reagent (Invitrogen) Spectramax M2 reader (Molecular Devices) manufacturerâ€™s
                                                  instructions.




                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                         Page 9


                              Immunoprecipitation
                                                  immunoprecipitation, 293 cell extract (200 Î¼l; 6â€“10 Î¼g/ Î¼l) brought 1ml
                                                  lysis buffer pre-cleared 1h 4Â°C 25 Î¼l Protein Sepharose (GE
NIH-PA Author Manuscript




                                                  Healthcare). supernatant immunoprecipitated 1h 4Â°C 25 Î¼l anti-
                                                  FLAGÂ®M2-Affinity Gel (Sigma). resin washed twice lysis buffer                                                   lysis buffer containing 300mM KCl. Immunoprecipitates eluted 3X red sample
                                                  buffer (NEB). anti-HA anti-DmPI31 immunoprecipitations, 25 Î¼l Protein                                                   Sepharose pre-incubated 2h anti-HA (3 Î¼l) anti-DmPI31 (5 Î¼l).                                                   resins washed times lysis buffer prior immunoprecipitation                                                   described  Embryo extracts used concentration 5 Î¼g/ Î¼l.

                              Proteasome activity Assay
                                                  50 Î¼g 0â€“2h WT (yw) embryo 3 Î¼g 293 cell extracts PIPES buffer (50mM PIPES,
                                                  1mMMgCl2, 50mM NaCl, 2mM EGTA 2mM ATP) programmed 1  DMSO
                                                  (Sigma), 5 Î¼M MG132 (Calbiochem), 2 Î¼M XAV939 (Sigma) 2 Î¼M IWR-1 (Sigma),
                                                  respectively, incubated 20 min room temperature. Samples assayed                                                   proteasome activity using Proteasome-Gloâ„¢ Chymotrypsin-like Cell-Based assay
                                                  (Promega) Spectramax M2 reader (Molecular Devices). assess effect ADP-
                                                  ribosylation 20S 26S proteasome activities purified bovine 20S 26S
                                                  proteasomes (0.1 Î¼g; UBPBio) PIPES buffer + 2mM ATP programmed 2 Î¼g
                                                  DmPI31WT, DmPI31Î”HbYX DmPI31ADPR, incubated 20 min NIH-PA Author Manuscript




                                                  room temperature. Samples assayed proteasome activity described 

                              Gel Filtration assay
                                                  2mg 0â€“2h WT embryo extracts prepared using PIPES buffer + 2mM ATP                                                   centrifuged twice 14 000 rpm 20 min 4Â°C prior treated 50 Î¼g 
                                                  DmPI31, 50 Î¼g DmPI31Î”HbYX, 50 Î¼g DmPI31ADP-ribosylation, 1  DMSO, 5 Î¼M
                                                  MG132, 2Î¼M XAV939 2 Î¼M Olaparib (LC laboratories) 30 min. Gel filtration
                                                  assay subsequently performed using Superose 6 10/300GL FPLC column (AKTA; GE
                                                  Healthcare). 500 Î¼l fractions collected using 0.250 ml/min flow rate. Purified bovine
                                                  19S, 20S 26S proteasomes (UBPBio), thyroglobulin, BSA used standards.

                              vitro ADP-ribosylation Assay Purification DmPI31ADPR
                                                  Recombinant DmPI31 (1 Î¼g), FLAG-dTNKS (0.1 Î¼g) dTNKSÎ”PARP (0.1 Î¼g),
                                                  biotin-NAD+ (3.5 Î¼M; Trevigen) incubated 5h 37Â°C subjected
                                                  SDS-PAGE followed Western Blotting using Streptavidin-HRP (Thermo-Scientific;
                                                  1:10000). Effect XAV939 dTNKS dPARP assessed incubating FLAG-
                                                  dTNKS FLAG-dPARP/Biotin-NAD+ mixture 0.1  DMSO 0.1 Î¼M
NIH-PA Author Manuscript




                                                  XAV939. purification DmPI31ADPR protein, vitro ADP-ribosylation                                                   recombinant DmPI31 protein performed  followed serial
                                                  purifications using TALON Metal Affinity resin (ClonTech) SoftLinkâ„¢ Soft Release
                                                  Avidin resin (Promega) manufacturesâ€™ instructions.

                              Native Gel analysis
                                                  analyze proteasome assembly status, 200 Î¼g embryo extracts exposed different
                                                  experimental conditions + 2mM ATP resolved using 5  Tris-HCl acrylamide gels
                                                  (Bio-rad) non-denaturing conditions transferred 0.22 Î¼m PVDF
                                                  membrane. Western blot analysis using specific antibodies performed described
                                                   Concentrations various reagents  1  DMSO, 5 Î¼M MG132, 2 Î¼M XAV939,
                                                  purified bovine 19S 20S (1 Î¼g), 5Î¼g DmPI31WT, DmPI31Î”HbYX                                                   DmPI31ADPR proteins.


                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                                              Page 10


                              Fly Strains
                                                  UAS-DTS5 UAS-DTS7 lines obtained J. Belote, dTNKS (21930, 21932                                                   106238), dp27 (28527, 47762 47763), dS5b (104492) dRpn14 (32697 32698)
NIH-PA Author Manuscript




                                                  RNAi lines obtained Vienna Drosophila RNAi Center (VDRC)                                                   Bloomington Drosophila Stock Center.

                              Supplementary Material
                                                  Refer Web version PubMed Central supplementary material.


                              Acknowledgments
                                                  alphabetical order, thank J. Belote providing fly strains; G. DeMartino,  Goldberg S. Larisch                                                   critical comments manuscript; S. Benjamin-Hong, O. Cho, B. Cho-Park, Y  Cho-Park, D. Ferres-Marco,
                                                  N. Gandagar, T. Hsiao,  Kelkar, L  Park, C. Pham, J. Rodriguez,  Sachrai, C. Sandu members lab
                                                  valuable discussions; J. Gee-Esposito, T. Gorenc, O. Matthew  Persaud logistical support. H.S.                                                   Investigator Howard Hughes Medical Institute. work supported NIH grant RO1GM60124                                                   H.S.


                              References
                                                  Bader M, Benjamin S, Wapinski OL, Smith DM, Goldberg AL, Steller H. conserved F box
NIH-PA Author Manuscript




                                                    regulatory complex controls proteasome activity Drosophila. Cell. 2011; 145:371â€“382. [PubMed:
                                                    21529711]
                                                  Barrault MB, Richet N, Godard C, Murciano B, Le Tallec B, Rousseau E, Legrand P, Charbonnier JB,
                                                    Le Du MH, Guerois R, et al. Dual functions Hsm3 protein chaperoning scaffolding
                                                    regulatory particle subunits proteasome assembly. Proc Natl Acad Sci U S  2012;
                                                    109:E1001â€“1010. [PubMed: 22460800]
                                                  Baumeister W, Walz J, Zuhl F, Seemuller E. proteasome: paradigm self-compartmentalizing
                                                    protease. Cell. 1998; 92:367â€“380. [PubMed: 9476896]
                                                  Belote JM, Fortier E. Targeted expression dominant negative proteasome mutants Drosophila
                                                    melanogaster. Genesis. 2002; 34:80â€“82. [PubMed: 12324954]
                                                  Besche HC, Haas W, Gygi SP, Goldberg AL. Isolation mammalian 26S proteasomes p97/VCP
                                                    complexes using ubiquitin-like domain HHR23B reveals novel proteasome-associated
                                                    proteins. Biochemistry. 2009a; 48:2538â€“2549. [PubMed: 19182904]
                                                  Besche HC, Peth  Goldberg AL. Getting base proteasome assembly. Cell. 2009b; 138:25â€“
                                                    28. [PubMed: 19596233]
                                                  Chambers JE, Petrova K, Tomba G, Vendruscolo M, Ron D. ADP ribosylation adapts ER
                                                    chaperone response short-term fluctuations unfolded protein load. J Cell Biol. 2012; 198:371â€“
                                                    385. [PubMed: 22869598]
NIH-PA Author Manuscript




                                                  Chen B, Dodge  Tang W, Lu J, Ma  Fan CW, Wei S, Hao W, Kilgore J, Williams NS, et al.
                                                    Small molecule-mediated disruption Wnt-dependent signaling tissue regeneration cancer.
                                                    Nat Chem Biol. 2009; 5:100â€“107. [PubMed: 19125156]
                                                  Chiang YJ, Hsiao SJ, Yver D, Cushman SW, Tessarollo L, Smith S, Hodes RJ. Tankyrase 1                                                     tankyrase 2 essential redundant mouse embryonic development. PLoS  2008;
                                                    3:e2639. [PubMed: 18612384]
                                                  Chiang YJ, Nguyen ML, Gurunathan S, Kaminker P, Tessarollo L, Campisi J, Hodes RJ. Generation
                                                      characterization telomere length maintenance tankyrase 2-deficient mice. Mol Cell Biol.
                                                      2006; 26:2037â€“2043. [PubMed: 16507984]
                                                  Chu-Ping M, Slaughter CA, DeMartino GN. Purification characterization protein inhibitor                                                       20S proteasome (macropain). Biochim Biophys Acta. 1992; 1119:303â€“311. [PubMed:
                                                      1312359]
                                                  Crosas B, Hanna J, Kirkpatrick DS, Zhang DP, Tone Y, Hathaway NA, Buecker C, Leggett DS,
                                                      Schmidt M, King RW, et al. Ubiquitin chains remodeled proteasome opposing
                                                      ubiquitin ligase deubiquitinating activities. Cell. 2006; 127:1401â€“1413. [PubMed: 17190603]


                                                           Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                                   Page 11


                                                  Dâ€™Amours D, Desnoyers S, Dâ€™Silva  Poirier GG. Poly(ADP-ribosyl)ation reactions regulation
                                                      nuclear functions. Biochem J. 1999; 342(Pt 2):249â€“268. [PubMed: 10455009]
                                                  Demartino GN, Gillette TG. Proteasomes: machines reasons. Cell. 2007; 129:659â€“662.
NIH-PA Author Manuscript




                                                      [PubMed: 17512401]
                                                  Deveraux Q, Jensen C, Rechsteiner M. Molecular cloning expression 26 S protease subunit
                                                      enriched dileucine repeats. J Biol Chem. 1995; 270:23726â€“23729. [PubMed: 7559544]
                                                  Finley D. Recognition processing ubiquitin-protein conjugates proteasome. Annu Rev
                                                      Biochem. 2009; 78:477â€“513. [PubMed: 19489727]
                                                  Funakoshi M, Tomko RJ Jr, Kobayashi H, Hochstrasser M. Multiple assembly chaperones govern
                                                      biogenesis proteasome regulatory particle base. Cell. 2009; 137:887â€“899. [PubMed:
                                                      19446322]
                                                  Gagne JP, Hendzel MJ, Droit  Poirier GG. expanding role poly(ADP-ribose) metabolism:
                                                      current challenges new perspectives. Curr Opin Cell Biol. 2006; 18:145â€“151. [PubMed:
                                                      16516457]
                                                  Gibson BA, Kraus WL. New insights molecular cellular functions poly(ADP-ribose)
                                                      PARPs. Nat Rev Mol Cell Biol. 2012; 13:411â€“424. [PubMed: 22713970]
                                                  Gillette TG, Kumar B, Thompson D, Slaughter CA, DeMartino GN. Differential roles COOH
                                                      termini AAA subunits PA700 (19 S regulator) asymmetric assembly activation                                                       26 S proteasome. J Biol Chem. 2008; 283:31813â€“31822. [PubMed: 18796432]
                                                  Glickman MH, Ciechanover  ubiquitin-proteasome proteolytic pathway: destruction sake
                                                      construction. Physiol Rev. 2002; 82:373â€“428. [PubMed: 11917093]
NIH-PA Author Manuscript




                                                  Goldberg AL. prions, proteasomes, mad cows. N Engl J Med. 2007; 357:1150â€“1152.
                                                      [PubMed: 17855677]
                                                  Goldberg AL. Development proteasome inhibitors research tools cancer drugs. J Cell Biol.
                                                      2012; 199:583â€“588. [PubMed: 23148232]
                                                  Gomes AV, Zong C, Edmondson RD, Li X, Stefani E, Zhang J, Jones RC, Thyparambil S, Wang GW,
                                                      Qiao X, et al. Mapping murine cardiac 26S proteasome complexes. Circ Res. 2006; 99:362â€“
                                                      371. [PubMed: 16857966]
                                                  Guettler S, LaRose J, Petsalaki E, Gish G, Scotter  Pawson T, Rottapel R, Sicheri F. Structural basis
                                                      sequence rules substrate recognition Tankyrase explain basis cherubism disease.
                                                      Cell. 2011; 147:1340â€“1354. [PubMed: 22153077]
                                                  Hanna J, Meides  Zhang DP, Finley D. ubiquitin stress response induces altered proteasome
                                                      composition. Cell. 2007; 129:747â€“759. [PubMed: 17512408]
                                                  Hershko  ubiquitin protein degradation roles control cell
                                                      division cycle. Cell Death Differ. 2005; 12:1191â€“1197. [PubMed: 16094395]
                                                  Hershko  Ciechanover  ubiquitin  Annu Rev Biochem. 1998; 67:425â€“479. [PubMed:
                                                      9759494]
                                                  Hsiao SJ, Poitras MF, Cook BD, Liu Y, Smith S. Tankyrase 2 poly(ADP-ribose) polymerase domain-
                                                      deleted mice exhibit growth defects normal telomere length capping. Mol Cell Biol.
NIH-PA Author Manuscript




                                                      2006; 26:2044â€“2054. [PubMed: 16507985]
                                                  Hsiao SJ, Smith S. Tankyrase function telomeres, spindle poles,  Biochimie. 2008;
                                                      90:83â€“92. [PubMed: 17825467]
                                                  Huang SM, Mishina YM, Liu S, Cheung  Stegmeier F, Michaud GA, Charlat O, Wiellette E, Zhang
                                                      Y, Wiessner S, et al. Tankyrase inhibition stabilizes axin antagonizes Wnt signalling. Nature.
                                                      2009; 461:614â€“620. [PubMed: 19759537]
                                                  Kaneko T, Hamazaki J, Iemura S, Sasaki K, Furuyama K, Natsume T, Tanaka K, Murata S. Assembly
                                                      pathway Mammalian proteasome base subcomplex mediated multiple specific
                                                      chaperones. Cell. 2009; 137:914â€“925. [PubMed: 19490896]
                                                  Kisselev AF, van der Linden WA, Overkleeft HS. Proteasome inhibitors: expanding army attacking
                                                      unique target. Chem Biol. 2012; 19:99â€“115. [PubMed: 22284358]
                                                  Kurucz E, Ando  Sumegi M, Holzl H, Kapelari B, Baumeister W, Udvardy  Assembly                                                       Drosophila 26 S proteasome accompanied extensive subunit rearrangements. Biochem J.
                                                      2002; 365:527â€“536. [PubMed: 11945175]



                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                                  Page 12


                                                  Lander GC, Estrin E, Matyskiela  Bashore C, Nogales E, Martin  Complete subunit architecture
                                                      proteasome regulatory particle. Nature. 2012; 482:186â€“191. [PubMed: 22237024]
                                                  Lasker K, Forster F, Bohn S, Walzthoeni T, Villa E, Unverdorben P, Beck F, Aebersold R, Sali 
NIH-PA Author Manuscript




                                                      Baumeister W. Molecular architecture 26S proteasome holocomplex determined                                                       integrative approach. Proc Natl Acad Sci U S  2012; 109:1380â€“1387. [PubMed: 22307589]
                                                  Lassot  Latreille D, Rousset E, Sourisseau M, Linares LK, Chable-Bessia C, Coux O, Benkirane M,
                                                      Kiernan  proteasome regulates HIV-1 transcription proteolytic nonproteolytic
                                                      mechanisms. Mol Cell. 2007; 25:369â€“383. [PubMed: 17289585]
                                                  Le Tallec B, Barrault MB, Guerois R, Carre T, Peyroche  Hsm3/S5b participates assembly
                                                      pathway 19S regulatory particle proteasome. Mol Cell. 2009; 33:389â€“399. [PubMed:
                                                      19217412]
                                                  Lee SY, la Mota-Peynado  Roelofs J. Loss Rpt5 protein interactions core particle                                                       Nas2 protein causes formation faulty proteasomes inhibited Ecm29 protein. J
                                                      Biol Chem. 2011; 286:36641â€“36651. [PubMed: 21878651]
                                                  Levaot N, Voytyuk O, Dimitriou  Sircoulomb F, Chandrakumar  Deckert M, Krzyzanowski PM,
                                                      Scotter  Gu S, Janmohamed S, et al. Loss Tankyrase-mediated destruction 3BP2                                                       underlying pathogenic mechanism cherubism. Cell. 2011; 147:1324â€“1339. [PubMed:
                                                      22153076]
                                                  Lindahl T, Satoh MS, Poirier GG, Klungland  Post-translational modification poly(ADP-ribose)
                                                      polymerase induced DNA strand breaks. Trends Biochem Sci. 1995; 20:405â€“411. [PubMed:
                                                      8533153]
NIH-PA Author Manuscript




                                                  McCutchen-Maloney SL, Matsuda K, Shimbara N, Binns DD, Tanaka K, Slaughter CA, DeMartino
                                                      GN. cDNA cloning, expression, functional characterization PI31, proline-rich inhibitor                                                       proteasome. J Biol Chem. 2000; 275:18557â€“18565. [PubMed: 10764772]
                                                  Morrone S, Cheng  Moon RT, Cong F, Xu W. Crystal structure Tankyrase-Axin complex                                                       implications Axin turnover Tankyrase substrate recruitment. Proc Natl Acad Sci U S 
                                                      2012; 109:1500â€“1505. [PubMed: 22307604]
                                                  Murata S, Yashiroda H, Tanaka K. Molecular mechanisms proteasome assembly. Nat Rev Mol Cell
                                                      Biol. 2009; 10:104â€“115. [PubMed: 19165213]
                                                  Narwal M, Venkannagari H, Lehtio L. Structural basis selective inhibition human tankyrases. J
                                                      Med Chem. 2012; 55:1360â€“1367. [PubMed: 22233320]
                                                  Nickell S, Mihalache O, Beck F, Hegerl R, Korinek  Baumeister W. Structural analysis 26S
                                                      proteasome cryoelectron tomography. Biochem Biophys Res Commun. 2007; 353:115â€“120.
                                                      [PubMed: 17173858]
                                                  Park S, Roelofs J, Kim W, Robert J, Schmidt M, Gygi SP, Finley D. Hexameric assembly                                                       proteasomal ATPases templated C termini. Nature. 2009; 459:866â€“870. [PubMed:
                                                      19412160]
                                                  Park Y, Hwang YP, Lee JS, Seo SH, Yoon SK, Yoon JB. Proteasomal ATPase-associated factor 1
                                                      negatively regulates proteasome activity interacting proteasomal ATPases. Mol Cell Biol.
                                                      2005; 25:3842â€“3853. [PubMed: 15831487]
NIH-PA Author Manuscript




                                                  Pause  Belsham GJ, Gingras AC, Donze O, Lin TA, Lawrence JC Jr, Sonenberg N. Insulin-
                                                      dependent stimulation protein synthesis phosphorylation regulator 5â€²-cap function.
                                                      Nature. 1994; 371:762â€“767. [PubMed: 7935836]
                                                  Peth  Besche HC, Goldberg AL. Ubiquitinated proteins activate proteasome binding                                                       Usp14/Ubp6, causes 20S gate opening. Mol Cell. 2009; 36:794â€“804. [PubMed: 20005843]
                                                  Peth  Kukushkin N, Bosse M, Goldberg AL. Ubiquitinated proteins activate proteasomal
                                                      ATPases binding Usp14 Uch37. J Biol Chem. 2013
                                                  Peth  Uchiki T, Goldberg AL. ATP-dependent steps binding ubiquitin conjugates                                                       26S proteasome commit degradation. Mol Cell. 2010; 40:671â€“681. [PubMed: 21095592]
                                                  Princiotta MF, Schubert U, Chen W, Bennink JR, Myung J, Crews CM, Yewdell JW. Cells adapted                                                       proteasome inhibitor 4-hydroxy- 5-iodo-3-nitrophenylacetyl-Leu-Leu-leucinal-vinyl sulfone
                                                      require enzymatically active proteasomes continued survival. Proc Natl Acad Sci U S  2001;
                                                      98:513â€“518. [PubMed: 11149939]



                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                                Page 13


                                                  Raab MS, Podar K, Breitkreutz  Richardson PG, Anderson KC. Multiple myeloma. Lancet. 2009;
                                                      374:324â€“339. [PubMed: 19541364]
                                                  Rabl J, Smith DM, Yu Y, Chang SC, Goldberg AL, Cheng Y. Mechanism gate opening 20S
NIH-PA Author Manuscript




                                                      proteasome proteasomal ATPases. Mol Cell. 2008; 30:360â€“368. [PubMed: 18471981]
                                                  Roelofs J, Park S, Haas W, Tian G, McAllister FE, Huo Y, Lee BH, Zhang F, Shi Y, Gygi SP, Finley
                                                      D. Chaperone-mediated pathway proteasome regulatory particle assembly. Nature. 2009;
                                                      459:861â€“865. [PubMed: 19412159]
                                                  Saeki Y, Toh EA, Kudo T, Kawamura H, Tanaka K. Multiple proteasome-interacting proteins assist
                                                      assembly yeast 19S regulatory particle. Cell. 2009; 137:900â€“913. [PubMed: 19446323]
                                                  Shim SM, Lee WJ, Kim Y, Chang JW, Song S, Jung YK. Role S5b/PSMD5 proteasome
                                                      inhibition caused TNF-alpha/NFkappaB higher eukaryotes. Cell Rep. 2012; 2:603â€“615.
                                                      [PubMed: 22921402]
                                                  Smith DM, Chang SC, Park S, Finley D, Cheng Y, Goldberg AL. Docking proteasomal
                                                      ATPasesâ€™ carboxyl termini 20S proteasomeâ€™s alpha ring opens gate substrate entry.
                                                      Mol Cell. 2007; 27:731â€“744. [PubMed: 17803938]
                                                  Smith S, Giriat  Schmitt  Lange T. Tankyrase, poly(ADP-ribose) polymerase human
                                                      telomeres. Science. 1998; 282:1484â€“1487. [PubMed: 9822378]
                                                  Tai HC, Besche H, Goldberg AL, Schuman EM. Characterization Brain 26S Proteasome                                                       Interacting Proteins. Mol Neurosci. 2010:3. [PubMed: 20407580]
                                                  Takagi K, Kim S, Yukii H, Ueno M, Morishita R, Endo Y, Kato K, Tanaka K, Saeki Y, Mizushima T.
                                                      Structural basis specific recognition Rpt1p, ATPase subunit 26 S proteasome, NIH-PA Author Manuscript




                                                      proteasome-dedicated chaperone Hsm3p. J Biol Chem. 2012; 287:12172â€“12182. [PubMed:
                                                      22334676]
                                                  Tanahashi N, Kawahara H, Murakami Y, Tanaka K. proteasome-dependent proteolytic 
                                                      Mol Biol Rep. 1999; 26:3â€“9. [PubMed: 10363639]
                                                  Tanaka K, Mizushima T, Saeki Y. proteasome: molecular machinery pathophysiological
                                                      roles. Biol Chem. 2012; 393:217â€“234. [PubMed: 23029643]
                                                  Tomko RJ Jr, Hochstrasser M. Order proteasomal ATPases eukaryotic proteasome
                                                      assembly. Cell Biochem Biophys. 2011; 60:13â€“20. [PubMed: 21461838]
                                                  Varshavsky  ubiquitin  immense realm. Annu Rev Biochem. 2012; 81:167â€“176.
                                                      [PubMed: 22663079]
                                                  Wang Y, Dawson VL, Dawson TM. Poly(ADP-ribose) signals mitochondrial AIF: key event                                                       parthanatos. Exp Neurol. 2009; 218:193â€“202. [PubMed: 19332058]
                                                  Watanabe TK, Saito  Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil
                                                      KB, Chung CH, Tanahashi N, Tanaka K. cDNA cloning characterization human
                                                      proteasomal modulator subunit, p27 (PSMD9). Genomics. 1998; 50:241â€“250. [PubMed: 9653651]
                                                  Yeh TY, Beiswenger KK, Li P, Bolin KE, Lee RM, Tsao TS, Murphy  Hevener AL, Chi NW.
                                                      Hypermetabolism, hyperphagia, reduced adiposity tankyrase-deficient mice. Diabetes.
                                                      2009; 58:2476â€“2485. [PubMed: 19651815]
NIH-PA Author Manuscript




                                                  Zaiss DM, Standera S, Holzhutter H, Kloetzel P, Sijts AJ. proteasome inhibitor PI31 competes
                                                      PA28 binding 20S proteasomes. FEBS Lett. 1999; 457:333â€“338. [PubMed: 10471803]
                                                  Zaiss DM, Standera S, Kloetzel PM, Sijts AJ. PI31 modulator proteasome formation                                                       antigen processing. Proc Natl Acad Sci U S  2002; 99:14344â€“14349. [PubMed: 12374861]




                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                  Page 14


                                                                                          Highlights
                                                  â€¢    TNKS modifies proteasome regulator PI31 ADP -ribosylation
NIH-PA Author Manuscript




                                                  â€¢    ADP-ribosylation alters PI31 affinity proteasome proteins
                                                  â€¢    TNKS regulates 26S proteasome activity controlling assembly
                                                  â€¢    TNKS-inhibitors represent new class agents block 26S assembly
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                      Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                     Page 15
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Figure 1. dTNKS, novel interacting partner DmPI31
                                                    dTNKS antiserum detects purified dTNKS. Purified FLAG-tagged dTNKS detected
                                                  Western blot dTNKS antiserum (lane 3), pre-immune serum (lane
                                                  2). (B) 0â€“2h yw (WT) embryo extract used anti-DmPI31 immunoprecipitation (IP)
                                                  demonstrate DmPI31 interacts dTNKS vivo. (C) DmPI31:dTNKS complex
                                                  form mammalian 293 cells. Anti-FLAG IP experiment performed using extracts
                                                  293 cells expressing FLAG-tagged dTNKS HA-tagged deIF4A (negative
                                                  control) DmPI31. (D) Schematic representation WT mutant dTNKS                                                   respective domains. Numbers denote amino acid positions. (E) dTNKS recruits DmPI31
                                                  ANK domain demonstrated IP experiment using 293 cell extracts
                                                  expressing HA-tagged DmPI31 FLAG-tagged dTNKSWT, dTNKS Î”SAM-PARP                                                   dTNKS Î”ANK. (F) Alignments TNKS-binding motif human 3BP2
NIH-PA Author Manuscript




                                                  (Guettler et al., 2011; Levaot et al., 2011) DmPI31 reveal presence putative
                                                  motif DmPI31. Numbers indicate position residues DmPI31. (G) dTNKS
                                                  interacts multiple DmPI31 surfaces: putative DmPI31 TNKS-binding motif
                                                  (RG49/54AA) conserved C-terminal residues (D211 P243) including HbYX-
                                                  domain. Figure S1.




                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                             Page 16
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Figure 2. dTNKS post-translationally modifies PI31 ADP-ribosylation regulate 26S
                                                  proteasome activity
                                                    DmPI31 poly ADP-ribosylated vivo. Endogenous DmPI31 ADP-ribosylation                                                   detected using 0â€“2h WT embryo extracts immuno-precipitated anti-DmPI31. Eluted
                                                  proteins analyzed Western blotting using anti-poly ADP-ribose (PAR) antibody.
                                                  (B) dTNKS directly ADP-ribosylates DmPI31 vitro dependent PARP
                                                  domain. Samples containing Biotin-NAD+, DmPI31, FLAG-dTNKSWT 
                                                  dTNKS Î”PARP analyzed ADP-ribosylation Western analysis. Input proteins
                                                  analyzed Western blotting (right panel). (C D) Tools used investigate
                                                  role TNKS 26S proteasome regulation. (C) XAV939 inhibits Drosophila TNKS
                                                  (dTNKS) vitro, indicating activity drug conserved species. (D)
                                                  siRNAs targeting hTNKS1 hTNKS2 efficiently knocked expressions 293 cells.
                                                  Î±-tubulin used loading control. (E F) TNKS inhibition XAV939 reduces
NIH-PA Author Manuscript




                                                  proteasome activity Drosophila embryo (E) 293 cell (F) extracts. (G) Reduced
                                                  hTNKS1 hTNKS2 levels inhibit 26S proteasome activity. (Eâ€“G) Data presented                                                   mean Â± standard deviation independent experiments. Values obtained DMSO
                                                  (Eâ€“F) control siRNA (G) set 100 . (E) *, p=0.01; (F) *, p=0.05; (G) *, p=0.04
                                                  **, p=0.006. Statistical analysis performed tailed, paired, t-test.                                                   Figure S2.




                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                       Page 17
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Figure 3. dTNKS dp27 RNAi enhances compromised proteasome activity
                                                  test dTNKS dp27 role modulating proteasome activity vivo, expressed
NIH-PA Author Manuscript




                                                  RNAi dTNKS (21930, 21932 106238; Câ€“E) dp27 (28527, 47762                                                   47763; Fâ€“L) background dominant-negative temperature sensitive mutants (UAS-
                                                  DTS5 UAS-DTS7) 29Â°C. expected, regulation factors resulted                                                   significant enhancement mutant rough reduced eye phenotype (compare panels B                                                   Câ€“L) dp27 RNAi lines, caused male lethality. observations indicative
                                                  reduced proteasome activities tissues. GMR-Gal4 expression caused                                                   discernable eye defects (panel . Orientation eyes anterior left dorsal 




                                                         Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                       Page 18
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Figure 4. ADP-ribosylation relieves 20S inhibition PI31
                                                    DmPI31 interacts 20S proteasomes select Î±-subunits: Î±1, Î±3, Î±4 Î±6. (B)
NIH-PA Author Manuscript




                                                  ADP-ribosylation significantly decreases affinity DmPI31 Î±4. FLAG- Î±4
                                                  expressing 293 cell extract incubated modified DmPI31  DmPI31ADPR) test
                                                  effect Î±4:DmPI31 complex. Chemoluminescence quantitated using
                                                  ImageQuant LAS-4000 (GE Healthcare). Î±4-binding reported relative                                                   immunoprecipitated DmPI31 compared level input DmPI31. (C)
                                                  Modification DmPI31 relieves inhibitory effect 20S proteasomes. Purified bovine
                                                  20S proteasomes (0.1 Î¼g) incubated DmPI31 DmPI31ADPR proteins
                                                  (2 Î¼g , chymotrypsin-like proteasome activity measured. Data presented                                                   mean Â± standard deviation independent experiments. value obtained 20S
                                                  proteasome set 100 . *, p=0.04, **, p=0.6 ***, p=0.045. Statistical analysis                                                   performed tailed, paired, t-test.




                                                          Cell. Author manuscript; available PMC 2013 October 25.
                            Cho-Park Steller                                                                                         Page 19
NIH-PA Author Manuscript
NIH-PA Author Manuscript




                                                  Figure 5. TNKS PI31 regulate proteasome assembly
                                                    Inhibition dTNKS XAV939 led drastic shift proteasome profile                                                   â€œlighterâ€? fractions, indicative reduced 26S particles. assess effect                                                   TNKS activity 26S assembly, embryo extracts treated XAV939 subjected                                                   Superose 6 gel filtration chromatography. (B) TNKS inhibition severely affects 26S
                                                  proteasome assembly. effect XAV939 proteasome assembly embryo extracts
                                                  assessed native gel analysis. (C) Similar XAV939, surplus DmPI31 dramatically
                                                  affected proteasome assembly. Furthermore, caused i